HomeTagsNeurotrophic Keratopathy

Neurotrophic Keratopathy

Biotechnology

Publication of RGN-259 Phase 3 Clinical Trial Results in Patients with Neurotrophic Keratopathy

PR Newswire - January 4, 2023

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting a new scientific publication describing the safety...

Biotechnology

RegeneRx Partner Submits Phase 3 Protocol for Neurotrophic Keratopathy (NK)

PR Newswire - September 28, 2022

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting that its U.S. joint venture (JV) partner...